Vleugel Marije M, Shvarts David, van der Wall Elsken, van Diest Paul J
Department of Pathology, University Medical Center Utrecht, 3508 GA Utrecht, The Netherlands.
Hum Pathol. 2006 Aug;37(8):1085-92. doi: 10.1016/j.humpath.2006.03.015. Epub 2006 Jun 19.
In previous studies, we noted that overexpression of hypoxia-inducible factor (HIF)-1alpha in breast cancer, especially the diffuse form, does not always lead to functional activation of its downstream genes. Transcriptional activity of HIF-1 may be repressed by p53 through competition for transcriptional coactivators such as p300. The aim of this study was therefore to explore the role of p53 and p300 in relation to overexpression of HIF-1alpha and activation of HIF-1 downstream genes in invasive breast cancer. p300 immunohistochemistry was performed in a group of 183 early-stage invasive breast cancers, and related to p53 accumulation, overexpression of HIF-1alpha, and several HIF-1 downstream genes. p300 was expressed in varying degrees in 84% of invasive breast cancers. p300 staining intensity correlated positively with HIF-1alpha expression (P = .04), p53 accumulation (P = .001), and overexpression of glucose transporter 1 (GLUT-1) (P < .001), a glucose transporter downstream target gene of HIF-1. GLUT-1 levels were significantly associated with p300 in HIF-1alpha positive patients (P = .02). p53 accumulation significantly positively correlated with carbonic anhydrase IX (CAIX)/GLUT-1 coexpression in HIF-1alpha-positive patients (P = .007). p53 accumulation/high p300 levels, the most favorable situation for HIF-1 downstream activation, were significantly associated with GLUT-1 overexpression (P = .01) and coexpression of CAIX/GLUT-1 (P = .03), compared with low p53/low p300 levels, the most unfavorable situation for HIF-1 downstream activation. p300 is a cofactor highly associated with p53 accumulation and HIF-1alpha levels in invasive breast cancer. Furthermore, low levels of p300 may explain absence of downstream effects in HIF-1alpha-overexpressing cancers, an effect that seems to be enhanced by wild-type levels of p53. This underlines the importance of p300 levels and p53 accumulation in the HIF-1-regulated response toward hypoxia.
在先前的研究中,我们注意到乳腺癌中缺氧诱导因子(HIF)-1α的过表达,尤其是弥漫形式,并不总是导致其下游基因的功能激活。HIF-1的转录活性可能会被p53通过竞争转录共激活因子如p300而抑制。因此,本研究的目的是探讨p53和p300在浸润性乳腺癌中与HIF-1α过表达及HIF-1下游基因激活的关系。对一组183例早期浸润性乳腺癌进行了p300免疫组化检测,并与p53积累、HIF-1α过表达及几个HIF-1下游基因相关联。84%的浸润性乳腺癌中p300呈不同程度表达。p300染色强度与HIF-1α表达呈正相关(P = 0.04),与p53积累呈正相关(P = 0.001),与葡萄糖转运蛋白1(GLUT-1)过表达呈正相关(P < 0.001),GLUT-1是HIF-1的葡萄糖转运下游靶基因。在HIF-1α阳性患者中,GLUT-1水平与p300显著相关(P = 0.02)。在HIF-1α阳性患者中,p53积累与碳酸酐酶IX(CAIX)/GLUT-1共表达呈显著正相关(P = 0.007)。与低p53/低p300水平(HIF-1下游激活最不利的情况)相比,p53积累/高p300水平(HIF-1下游激活最有利的情况)与GLUT-1过表达(P = 0.01)及CAIX/GLUT-1共表达(P = 0.03)显著相关。p300是一种与浸润性乳腺癌中p53积累和HIF-1α水平高度相关的辅因子。此外,低水平的p300可能解释了HIF-1α过表达癌症中缺乏下游效应的现象,而野生型p53水平似乎会增强这种效应。这突出了p300水平和p53积累在HIF-1调节的缺氧反应中的重要性。